Applicability of the Finnish Diabetes Risk (FINDRISC) as a Screening Tool for Type 2 Diabetes Mellitus

Basit Öğe Kaydı
dc.contributor.authorKutlu, Ruhusen
dc.contributor.authorSayin, Seher
dc.contributor.authorKocak, Ahmet
dc.date.accessioned2024-02-23T14:48:48Z
dc.date.available2024-02-23T14:48:48Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstractObjective: In this study, we aimed to investigate the applicability of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for undiagnosed Type 2 Diabetes Mellitus. Methods: This cross-sectional analytic study was carried out on 479 persons referred to the Outpatient Clinic of Family Medicine. The risk of developing Type 2 diabetes mellitus was assessed using the FINDRISC. LDL-c, HDL-c, total cholesterol, triglyceride, glucose and insulin levels were measured in the blood of the patients taken after 10-12 hours of fasting. For insulin resistance, HOMA IR (Homeostasis Model Assessment) was calculated by using fasting plasma glucose (FBG) and insulin levels. Results: In all the participants, 73.9% (n=354) were female, 26.1% (n=125) were male, the mean age was 35.14 +/- 10.77. The Diabetes risk was increasing with low education level, marriage, unemployment, obesity and sedentary lifestyle. Age, BMI, waist circumference, hip circumference, systolic and diastolic blood pressure were significantly higher in the high and very high risk group than other groups (p<0.001). A significant positive correlation were found between the FINDRISC score and FBG, insulin, total cholesterol, triglycerides, LDL-c, as well as a negative correlation with HDL-c level (p<0.001). The frequency of insulin resistance were higher in the moderate risk group, this difference was statistically very significant (p<0.001). Conclusion: Type 2 diabetes is a major health problem in our country as well as all over the world. FINDRISC can be used as a simple and noninvasive screening tool to identify individuals at high risk for diabetes in the adults.en_US
dc.identifier.endpage166en_US
dc.identifier.issn1309-3878
dc.identifier.issue3en_US
dc.identifier.startpage158en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17842
dc.identifier.volume8en_US
dc.identifier.wosWOS:000392948600002en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherDuzce Univen_US
dc.relation.ispartofKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.subjectFindriscen_US
dc.subjectScreening Methoden_US
dc.titleApplicability of the Finnish Diabetes Risk (FINDRISC) as a Screening Tool for Type 2 Diabetes Mellitusen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu